ClearLLab 10C Panels (B, T, M1, M2), Navios Flow Cytometer, Navios EX Flow Cytometer

FDA 510(k) K183592 · Beckman Coulter

Substantially Equivalent

510(k) numberK183592

Submission

Device name
ClearLLab 10C Panels (B, T, M1, M2), Navios Flow Cytometer, Navios EX Flow Cytometer
Applicant
Beckman Coulter
Miami, FL, US
Received
December 21, 2018
Decision date
March 21, 2019
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
PWD – Flow Cytometric Test System For Hematopoietic Neoplasms
Device class
Class II (moderate risk)
Regulation
21 CFR 864.7010
Specialty
Hematology

Reagents intended for in vitro diagnostic use as a panel for qualitative identification of cell populations by multiparameter immunophenotyping on a flow cytometer. These reagents are used as an aid in the differential diagnosis of hematologically abnormal patients having, or suspected of having the following hematopoietic neoplasms: chronic leukemia, acute leukemia, non-Hodgkin's lymphoma…

More from Beckman Coulter

510(k)DeviceDecision
K252169Access BNP IINBC · Traditional 03/24/2026SE
K254059Access anti-HBc IgMSEI · Traditional 03/13/2026SE
K253687Access anti-HBc TotalSEI · Traditional 02/19/2026SE
K251995Access anti-HAV IgMLOL · Traditional 01/27/2026SE
K250588Access Rubella IgGLFX · Traditional 11/17/2025SE
K252580iQ200 SeriesLKM · Special 09/10/2025SE
K243846Access anti-HAVLOL · Traditional 09/09/2025SE
K243804MicroScan Dried Gram-Negative MIC/Combo Panels with Cefepime (CPE) (0.12-64 µg/mL)…LTT · Traditional 08/20/2025SE
K250036MicroScan Dried Gram-Positive MIC/Combo Panels with Daptomycin (DAP) (0.06-32 µg/mL)LTT · Traditional 08/15/2025SE
K243483Access hsTnIMMI · Traditional 08/01/2025SE

Questions and answers

When was ClearLLab 10C Panels (B, T, M1, M2), Navios Flow Cytometer, Navios EX Flow Cytometer cleared by the FDA?

ClearLLab 10C Panels (B, T, M1, M2), Navios Flow Cytometer, Navios EX Flow Cytometer (K183592) received a 510(k) decision of Substantially Equivalent on March 21, 2019, 90 days after the submission was received.

What is the product code of K183592?

The FDA product code is PWD – Flow Cytometric Test System For Hematopoietic Neoplasms, a Class II (moderate risk) device regulated under 21 CFR 864.7010.